title: UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
authors: Avon Haematology Unit, Bristol Haematology and Oncology Centre, Bristol, UK. bcsh@b-s-h.org.uk
authors: Jenny
authors: J
authors: Bird
authors: Judith
authors: J
authors: Behrens
authors: Jan
authors: J
authors: Westin
authors: Ingemar
authors: I
authors: Turesson
authors: Mark
authors: M
authors: Drayson
authors: Robert
authors: R
authors: Beetham
authors: Shirley
authors: S
authors: D'Sa
authors: Richard
authors: R
authors: Soutar
authors: Anders
authors: A
authors: Waage
authors: Nina
authors: N
authors: Gulbrandsen
authors: Henrik
authors: H
authors: Gregersen
authors: Eric
authors: E
authors: Low
mesh_terms: D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D002471:Cell Transformation, Neoplastic; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D008134:Long-Term Care / Q000379:methods; D008232:Lymphoproliferative Disorders / Q000175:diagnosis; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis* / Q000453:epidemiology; D009101:Multiple Myeloma / Q000175:diagnosis; D011379:Prognosis; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis
chemical_list: D015415:Biomarkers; D007136:Immunoglobulins; C009823:M-proteins (Myeloma)